These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15926798)

  • 1. Screening of protein kinases by ATP-STD NMR spectroscopy.
    McCoy MA; Senior MM; Wyss DF
    J Am Chem Soc; 2005 Jun; 127(22):7978-9. PubMed ID: 15926798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel synthesis and structural characterization of a high-affinity paramagnetic kinase probe for the identification of non-ATP site binders by nuclear magnetic resonance.
    Moy FJ; Lee A; Gavrin LK; Xu ZB; Sievers A; Kieras E; Stochaj W; Mosyak L; McKew J; Tsao DH
    J Med Chem; 2010 Feb; 53(3):1238-49. PubMed ID: 20038108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors.
    Laufer SA; Domeyer DM; Scior TR; Albrecht W; Hauser DR
    J Med Chem; 2005 Feb; 48(3):710-22. PubMed ID: 15689155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for the NMR-based identification and optimization of allosteric protein kinase inhibitors.
    Jahnke W; Blommers MJ; Fernández C; Zwingelstein C; Amstutz R
    Chembiochem; 2005 Sep; 6(9):1607-10. PubMed ID: 16028302
    [No Abstract]   [Full Text] [Related]  

  • 5. kinDOCK: a tool for comparative docking of protein kinase ligands.
    Martin L; Catherinot V; Labesse G
    Nucleic Acids Res; 2006 Jul; 34(Web Server issue):W325-9. PubMed ID: 16845019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP.
    Bao H; Kasten SA; Yan X; Roche TE
    Biochemistry; 2004 Oct; 43(42):13432-41. PubMed ID: 15491150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Fluoro-ATP as a versatile tool for 19F NMR-based activity screening.
    Stockman BJ
    J Am Chem Soc; 2008 May; 130(18):5870-1. PubMed ID: 18407634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
    Chuaqui C; Deng Z; Singh J
    J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling kinase-substrate specificity: implication of the distance between substrate nucleophilic oxygen and attacked phosphorus of ATP analog on binding affinity.
    Sun M; Liu XH; Ji SH; Zhao YF
    J Mol Graph Model; 2005 Apr; 23(5):433-8. PubMed ID: 15781185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases.
    Nam NH; Lee S; Ye G; Sun G; Parang K
    Bioorg Med Chem; 2004 Nov; 12(22):5753-66. PubMed ID: 15498652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ligand binding to N-acetylglucosamine kinase studied by STD NMR.
    Blume A; Berger M; Benie AJ; Peters T; Hinderlich S
    Biochemistry; 2008 Dec; 47(49):13138-46. PubMed ID: 19006331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis.
    Huang D; Zhou T; Lafleur K; Nevado C; Caflisch A
    Bioinformatics; 2010 Jan; 26(2):198-204. PubMed ID: 19942586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.
    Bogoyevitch MA; Fairlie DP
    Drug Discov Today; 2007 Aug; 12(15-16):622-33. PubMed ID: 17706543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A universal and multiplex kinase assay using γ-[(18)O(4)]-ATP.
    Fu C; Zheng X; Jiang Y; Liu Y; Xu P; Zeng Z; Liu R; Zhao Y
    Chem Commun (Camb); 2013 Apr; 49(27):2795-7. PubMed ID: 23439932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR screening applied to the fragment-based generation of inhibitors of creatine kinase exploiting a new interaction proximate to the ATP binding site.
    Bretonnet AS; Jochum A; Walker O; Krimm I; Goekjian P; Marcillat O; Lancelin JM
    J Med Chem; 2007 Apr; 50(8):1865-75. PubMed ID: 17375903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-ligand interactions: identification and characterization of ligand binding by NMR spectroscopy.
    Benie AJ; Moser R; Bäuml E; Blaas D; Peters T
    J Am Chem Soc; 2003 Jan; 125(1):14-5. PubMed ID: 12515488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of characteristic structural features of ligand binding sites of protein kinases: a neural network approach.
    Niwa T
    J Chem Inf Model; 2006; 46(5):2158-66. PubMed ID: 16995746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface-plasmon-resonance-based biosensor with immobilized bisubstrate analog inhibitor for the determination of affinities of ATP- and protein-competitive ligands of cAMP-dependent protein kinase.
    Viht K; Schweinsberg S; Lust M; Vaasa A; Raidaru G; Lavogina D; Uri A; Herberg FW
    Anal Biochem; 2007 Mar; 362(2):268-77. PubMed ID: 17274940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined STD-NMR/molecular modeling protocol for predicting the binding modes of the glycosidase inhibitors kifunensine and salacinol to Golgi alpha-mannosidase II.
    Wen X; Yuan Y; Kuntz DA; Rose DR; Pinto BM
    Biochemistry; 2005 May; 44(18):6729-37. PubMed ID: 15865418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors.
    Meyer B; Peters T
    Angew Chem Int Ed Engl; 2003 Feb; 42(8):864-90. PubMed ID: 12596167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.